Back to Search
GARY DUBIN, M.D.
M.D.
Internal Medicine Physician
NPI: 1285924589Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MD038154E(PA)
Research & Publications (20)
Enzymatic activity of the Staphylococcus aureus SplB serine protease is induced by substrates containing the sequence Trp-Glu-Leu-Gln.
PMID 18448121·J Mol Biol·2008
7-preclinical
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.
PMID 17602732·Lancet·2007
4-observational
The staphostatin family of cysteine protease inhibitors in the genus Staphylococcus as an example of parallel evolution of protease and inhibitor specificity.
PMID 17261086·Biol Chem·2007
7-preclinical
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.
PMID 19586656·Lancet·2009
3-trial
High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx.
PMID 19305137·Cell Cycle·2009
8-other
Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials.
PMID 19221517·Hum Vaccin·2009
8-other
Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses.
PMID 19217149·Gynecol Oncol·2009
8-other
Structural and functional characterization of SplA, an exclusively specific protease of Staphylococcus aureus.
PMID 19175361·Biochem J·2009
7-preclinical
Immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in healthy boys aged 10-18 years.
PMID 19101456·J Adolesc Health·2009
4-observational
Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15-55 years.
PMID 19022320·Vaccine·2009
3-trial
Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines.
PMID 18845199·Vaccine·2008
1-meta
Staphylococcus aureus infection triggers production of neutralizing, V8 protease-specific antibodies.
PMID 18205806·FEMS Immunol Med Microbiol·2008
7-preclinical
The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin.
PMID 17973626·Biochem J·2008
8-other
Seroprevalence of herpes simplex virus type 1 in children in the United States.
PMID 17889072·J Pediatr·2007
8-other
Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial.
PMID 17699008·JAMA·2007
3-trial
Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant.
PMID 17531764·J Adolesc Health·2007
2-rct
Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults.
PMID 17485150·Vaccine·2007
3-trial
Staphylococcus aureus-derived staphopain B, a potent cysteine protease activator of plasma chemerin.
PMID 17339469·J Immunol·2007
7-preclinical
Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing.
PMID 16925896·Int J STD AIDS·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1549 TANGLEWOOD DR
WEST CHESTER, PA 19380 - Phone
- (610) 651-0827
Quick Facts
- NPI
- 1285924589
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile